Dramatic reduction of the α-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis

Journal of Clinical Gastroenterology

Volumn 36, Issue 5, 2003, Pages 440-442

  Yao, Francis Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fetoprotein; Hepatitis B; Lamivudine

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; DIURETIC AGENT; FUROSEMIDE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; SPIRONOLACTONE; VIRUS DNA;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; ASCITES; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ECHOGRAPHY; FLUID RETENTION; FOLLOW UP; HEPATITIS B; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VIRUS DIAGNOSIS; VIRUS REPLICATION;

ADULT; ALPHA-FETOPROTEINS; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 0037404384     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200305000-00017     Document Type: Article

References (7)

1. Johnson PJ. The role of serum alphafetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liv Dis 2001;5:145-59.
2. Lok ASF, Lai CL. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989;9:110-5.
3. Lee HS, Chung YH, Kim CY. Specificities of serum alpha-fetoprotein levels in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Hepatology 1991;14:68-72.
4. Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-8.
5. Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment of chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
6. Yao FY, Terrault NA, Freise C, et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001;34:411-6.
7. Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and retakeover by wild type after cessation of therapy. Hepatology 1998;27:1711-6.